Effects of delay in infusion of N-acetylcysteine on appearance of adverse drug reactions after acetaminophen overdose: A retrospective study

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 10, 2010, Pages 1064-1070

  Zyoud, Sa'ed H ^a,b   Awang, Rahmat ^a   Syed Sulaiman, Syed Azhar ^a   Al Jabi, Samah W ^a,b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

Acetaminophen; Adverse drug reaction; Cutaneous anaphylactoid reactions; N acetylcysteine; Overdose

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL;

ACUTE DRUG ADMINISTRATION; ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; COMPARATIVE STUDY; CONTROLLED STUDY; CONVULSION; COUGHING; DISEASE ASSOCIATION; DIZZINESS; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG OVERDOSE; DYSPNEA; ECG ABNORMALITY; FEMALE; FLUSHING; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONPARAMETRIC TEST; OUTCOME ASSESSMENT; PARAMETRIC TEST; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN ANAPHYLAXIS; TACHYCARDIA; THERAPY DELAY; THORAX PAIN; VOMITING; WHEEZING;

ACETAMINOPHEN; ACETYLCYSTEINE; ADULT; ANAPHYLAXIS; ANTIDOTES; FEMALE; HUMANS; MALE; OVERDOSE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 78650443608     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1955     Document Type: Article

References (29)

1. Nourjah P, Ahmad SR, Karwoski C, et al. Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006; 15: 398-405.
2. Rajasuriar R, Awang R, Hashim SB, et al. Profile of poisoning admissions in Malaysia. Hum Exp Toxicol 2007; 26: 73-81.
3. Chun LJ, Tong MJ, Busuttil RW, et al. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009; 43: 342-349.
4. Waring WS, Jamie H, Leggett GE. Delayed onset of acute renal failure after significant paracetamol overdose: a case series. Hum Exp Toxicol 2010; 29: 63-68.
5. Prescott LF. Paracetamol (Acetaminophen). A Critical Bibliographic Review. Taylor & Francis: London, 1996.
6. Perry HE, Shannon MW. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label clinical trial. J Pediatr 1998; 132: 149-152.
7. Kanter MZ. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 2006; 63: 1821-1827.
8. Wright RO, Anderson AC, Lesko SL, et al. Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose. J Toxicol Clin Toxicol 1999; 37: 35-42.
9. Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2: 1097-1100.
10. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009; 47: 81-88.
11. Lynch RM, Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004; 12: 10-15.
12. Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001; 51: 87-91.
13. Kozer E, Koren G. Management of paracetamol overdose: current controversies. Drug Saf 2001; 24: 503-512.
14. Whyte IM, Francis B, Dawson AH. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database. Curr Med Res Opin 2007; 23: 2359-2368.
15. Waring WS, Stephen AF, Robinson OD, et al. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol 2008; 46: 496-500.
16. Pakravan N, Waring WS, Sharma S, et al. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol (Phila) 2008; 46: 697-702.
17. Kao LW, Kirk MA, Furbee RB, et al. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning? Ann Emerg Med 2003; 42: 741-750.
18. Gheshlagi F, Izadi-Mood N, Amini R, et al. Prevalence of hypersensitivity reactions to intravenous N-acetylcysteine in acetaminophen poisoned patients. Clin Toxicol (Phila) 2005; 43: 514-515.
19. Merl W, Koutsogiannis Z, Kerr D, et al. How safe is intravenous N-acetylcysteine for the treatment of paracetamol poisoning? Hong Kong J Emerg Med 2007; 14: 198-203.
20. Appelboam AV, Dargan PI, Knighton J. Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma. Emerg Med J 2002; 19: 594-595.
21. Mant TG, Tempowski JH, Volans GN, et al. Adverse reactions to acetylcysteine and effects of overdose. Br Med J (Clin Res Ed) 1984; 289: 217-219.
22. Zyoud SH, Awang R, Syed Sulaiman SA, et al. Incidence of adverse drug reactions induced by N-acetylcysteine in patients with acetaminophen overdose. Hum Exp Toxicol 2010; 29: 153-160.
23. Rumack BH, Peterson RC, Koch GG, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 1981; 141: 380-385.
24. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55: 871-876.
25. Vale JA, Meredith TJ, Crome P, et al. Intravenous N-acetylcysteine: the treatment of choice in paracetamol poisoning? Br Med J 1979; 2: 1435-1436.
26. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998; 31: 710-715.
27. Wright RO, Santucci KA. Are shorter courses of N-acetylcysteine for acetaminophen poisoning efficacious? A review of the literature. Clin Pediatr Emerg Med 2000; 1: 222-228.
28. Huitema AD, Soesan M, Meenhorst PL, et al. A dose-dependent delayed hypersensitivity reaction to acetaminophen after repeated acetaminophen intoxications. Hum Exp Toxicol 1998; 17: 406-408.
29. Daly FF, Fountain JS, Murray L, et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand-explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008; 188: 296-301.